Literature DB >> 3767685

Juxtacanalicular tissue in primary open angle glaucoma and in nonglaucomatous normals.

J A Alvarado, A J Yun, C G Murphy.   

Abstract

The juxtacanalicular (JXT) tissue was evaluated in 64 specimens from 36 nonglaucomatous normal persons and 28 specimens from 26 patients with primary open angle glaucoma (POAG). Morphometry was performed on more than 2000 electron micrographs taken from the entire JXT region of each of the 64 specimens studied. The concentration of three electron-dense materials (EDMs) believed to obstruct the JXT tissue in POAG was measured using precise and reproducible morphometric methods. There is a great deal of variability in the EDM concentration, but we could still measure a significant increase in EDM of about 0.2% each year in normal specimens. Specimens from patients with POAG who are younger than 40 years of age have an EDM concentration similar to that in normal specimens. After the approximate age of 40 years, a significant difference is observed in the EDM concentration between nonglaucomatous and POAG specimens. This difference represents an average increase of 23% in POAG. Such a difference is probably too small to account for the decrease in outflow facility characteristic of POAG.

Entities:  

Mesh:

Year:  1986        PMID: 3767685     DOI: 10.1001/archopht.1986.01050220111038

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  22 in total

1.  In situ autofluorescence visualization of human trabecular meshwork structure.

Authors:  James C H Tan; Jose M Gonzalez; Sarah Hamm-Alvarez; Jonathan Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

2.  Imaging the aqueous humor outflow pathway in human eyes by three-dimensional micro-computed tomography (3D micro-CT).

Authors:  Cheryl R Hann; Michael D Bentley; Andrew Vercnocke; Erik L Ritman; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2010-12-25       Impact factor: 3.467

Review 3.  'What controls aqueous humour outflow resistance?'.

Authors:  Mark Johnson
Journal:  Exp Eye Res       Date:  2006-01-04       Impact factor: 3.467

4.  Effects of Y27632 on aqueous humor outflow facility with changes in hydrodynamic pattern and morphology in human eyes.

Authors:  Chen-Yuan Charlie Yang; Ye Liu; Zhaozeng Lu; Ruiyi Ren; Haiyan Gong
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

5.  Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.

Authors:  Darryl R Overby; Jacques Bertrand; Ozan-Yüksel Tektas; Alexandra Boussommier-Calleja; Martin Schicht; C Ross Ethier; David F Woodward; W Daniel Stamer; Elke Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-15       Impact factor: 4.799

6.  Outflow tract ablation using a conditionally cytotoxic feline immunodeficiency viral vector.

Authors:  Ze Zhang; Amardeep S Dhaliwal; Harry Tseng; James D Kim; Joel S Schuman; Robert N Weinreb; Nils A Loewen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-18       Impact factor: 4.799

7.  Two-photon imaging of the trabecular meshwork.

Authors:  David A Ammar; Tim C Lei; Emily A Gibson; Malik Y Kahook
Journal:  Mol Vis       Date:  2010-05-29       Impact factor: 2.367

8.  Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility.

Authors:  Zhou Wan; David F Woodward; W Daniel Stamer
Journal:  Expert Rev Ophthalmol       Date:  2008

9.  Proteomic analysis of rat retina in a steroid-induced ocular hypertension model: potential vulnerability to oxidative stress.

Authors:  Nariko Miyara; Manabu Shinzato; Yoshito Yamashiro; Akihiro Iwamatsu; Ken-Ichi Kariya; Shoichi Sawaguchi
Journal:  Jpn J Ophthalmol       Date:  2008-04-30       Impact factor: 2.447

10.  RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma.

Authors:  Mao Li; Jianjiang Xu; Xueli Chen; Xinghuai Sun
Journal:  Diagn Pathol       Date:  2009-12-16       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.